Company: OSRH
Filing Date: 2025-08-19
Form Type: PRE 14A
Source: 0001213900-25-078140
Chunk: 39

Company: OSR Holdings, Inc.
Filing Date: 2025-08-19
Form: PRE 14A
Chunk 39
---
 into or exercisable for common stock) equal to 20% or more of the common stock or 20% or more of the voting
power outstanding before the issuance for a price that is less than the lower of: (i) the closing price of the common stock immediately
preceding the signing of the binding agreement for the issuance of such securities; or (ii) the average closing price of the common stock
for the five trading days immediately preceding the signing of the binding agreement for the issuance of such securities (the “Minimum
Price”). Based upon Nasdaq Listing Rule 5635(d), we cannot issue in excess of 3,853,467 shares of our common stock as
of the date of the Common Stock Purchase Agreement upon conversion of the Note, exercise of the Warrant, unless the issuance of such excess
shares are approved by our stockholders.

As noted above, because
the ELOC Agreement accordingly prohibits our issuance of the company’s common equity in excess of 19.99% stockholder approval to
exceed such level is first obtained, we are asking stockholders to approve the issuance of 20% or more of common stock to White Lion.

Our board of directors
is not seeking the approval of our stockholders to authorize our entry into the ELOC Agreement, as we have already entered into the ELOC
Agreement on February 25, 2025. We are only asking for approval to issue to White Lion, 20% or more of our issued and outstanding common
stock as constituted on February 25, 2025.

Effect on Current Stockholders if the Nasdaq 20% Issuance Proposal is Approved

Each additional share of our common stock that would be issuable
to White Lion would have the same rights and privileges as each share of our currently outstanding common stock. The issuance of shares
of our common stock to White Lion pursuant to the terms of the ELOC Agreement will not affect the rights of the holders of our outstanding
common stock, but such issuances will have a dilutive effect on the existing stockholders, including the voting power and economic rights
of the existing stockholders, and may result in a decline in our stock price or greater price volatility in the short term. Further, any
sales in the public market of our shares of common stock issuable to White Lion could adversely affect prevailing market prices of our
shares of common stock.

Vote Required

In order for this Nasdaq 20% Issuance Proposal to be approved,